Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.35
+0.05 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
11.39
+0.04 (0.35%)
After-hours: Mar 9, 2026, 5:26 PM EDT

Keros Therapeutics Revenue

In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth. Keros Therapeutics had revenue of $385.00K in the quarter ending December 31, 2025, a decrease of -87.34%.

Revenue (ttm)
$244.06M
Revenue Growth
+6,774.96%
P/S Ratio
0.92
Revenue / Employee
$3,128,987
Employees
78
Market Cap
223.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Protalix BioTherapeutics 61.84M
Editas Medicine 40.52M
Voyager Therapeutics 40.37M
MediWound 16.96M
Cartesian Therapeutics 2.80M
Humacyte 1.57M
Revenue Rankings

KROS News

More News